Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Cancer Research|July 3, 2004
Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiationPo-Lin So, Kenneth Lee, Jennifer Hebert, et al.Investigational New Drugs|April 2, 2008
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?Andrew H Ko, Elizabeth Dito, Brian Schillinger, et al.JAMA Oncology|November 11, 2016
Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical TrialMichelle E Melisko, Mindy E Goldman, Jimmy Hwang, et al.Breast Cancer Research and Treatment|July 17, 2012
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivorsMeredith Bock, Dan Moore, Jimmy Hwang, et al.Journal of the American College of Surgeons|December 5, 2009
Clinical spectrum of pheochromocytomaMarlon A Guerrero, Jennifer M J Schreinemakers, Menno R Vriens, et al.Cancer Chemotherapy and Pharmacology|March 26, 2014
A phase I study of oral ixabepilone in patients with advanced solid tumorsJohn F Deeken, John L Marshall, Michael J Pishvaian, et al.Cancer Chemotherapy and Pharmacology|February 5, 2010
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancerAndrew H Ko, Alan P Venook, Emily K Bergsland, et al.World Journal of Surgery|March 8, 2008
Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13Gustavo G Fernandez-Ranvier, Julie Weng, Ru-Fang Yeh, et al.Head & Neck|May 15, 2014
Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large seriesMarie-Adele S Kress, Neilayan Sen, Keith R Unger, et al.Cancer|February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignanciesJohn F Deeken, Hongkun Wang, Deepa Subramaniam, et al.Pageof 9